Bill Ackman Valeant

  • Featured Story


    The Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) stock price has dropped 44% year to date and nearly 80% over the last three months.

    While some are saying VRX stock has now become undervalued, Money Morning Global Credit Strategist Michael Lewitt says the Valeant stock price will only continue to fall.

    Here's why...

Article Index

Sorry, no content matched your criteria.